Strategic Advocates’s Equinor EQNR Stock Holding History

Strategic Advocates’s Portfolio EQNR Stock Details EQNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,000	Closed	-$42.2K	–	268
2026 Q1	$42.2K	Hold	1,000	–	–	0.19%	84
2025 Q4	$23.6K	Hold	1,000	–	–	0.01%	267
2025 Q3	$24.4K	Buy	+1,000	New	+$25.1K	0.01%	263

Other funds holding EQNR

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $23.5B AUM 33.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Strategic Advocates's EQNR Position: Q2 2026 in Review

Strategic Advocates sold out of Equinor (EQNR) in Q2 2026, closing a stake of 1,000 shares — an estimated $42.2K sold.

Strategic Advocates first reported a position in EQNR in Q3 2025 and held it in 3 quarters. The position peaked at $42.2K in Q1 2026. 412 funds tracked by Wall St. Rank hold EQNR as of Q2 2026.

Strategic Advocates reported no remaining Equinor position as of Q2 2026 after selling out during the quarter.
Strategic Advocates sold 1,000 Equinor shares in Q2 2026, an estimated $42.2K.
Strategic Advocates first reported a position in Equinor in Q3 2025 and held it in 3 quarters.
Strategic Advocates's Equinor position peaked at $42.2K in Q1 2026.
412 funds tracked by Wall St. Rank held Equinor as of Q2 2026.

Based on Strategic Advocates's 13F filing for Q2 2026, filed 13 Aug 2026.